Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The TEN1-CDK3 readthrough locus is a naturally occurring transcript that spans the adjacent TEN1 and CDK3 genes on chromosome 17[1][3][7]. This transcript is classified as a candidate for nonsense-mediated mRNA decay and is generally not translated into a protein product. TEN1 by itself is a protein involved in the CST complex, which is essential for telomere end protection and length regulation, acting in concert with proteins such as STN1 and Cdc13[2][4][6]. However, the TEN1-CDK3 readthrough does not encode a functional protein and is not characterized as a molecular target for therapeutic intervention. If you require structured data about individual protein-coding genes (TEN1 or CDK3), each has well-documented functions: TEN1 is critical for telomere maintenance, whereas CDK3 is a cyclin-dependent kinase involved in cell cycle regulation[4][5][6]. This specific readthrough transcript is mostly considered a transcriptional byproduct with no established direct roles in molecular targeting or disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TEN1-CDK3 readthrough (non-protein coding) (TEN1-CDK3).